RANI
Rani Therapeutics Holdings, Inc.$0.84-0.00 (-0.06%)Prev Close$0.84·MCap$56.0M·P/E—·Vol648.5K·Yield—
▲
Buys (12M)
3
$1.31M
▼
Sells (12M)
2
$11.6K
◆
Net Activity
Net Buyer
$1.30M
●
Active Insiders
4
last 12 mo
Over the past 12 months, insider activity at Rani Therapeutics Holdings, Inc. (RANI) has been dominated by buying, with 3 insider purchases totaling $1.31M and 2 insider sales totaling $11.6K. The most recent insider transaction was by IMRAN MIR A (director, 10 percent owner: ), who purchased $24.8K worth of shares on Jul 23, 2026. Rani Therapeutics Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $56.0M.
RANI Insider Trading Activity
Showing 1–50 of 60
1 / 2
RANI Insider Buying Activity
The following table shows recent insider purchases of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
RANI Insider Selling Activity
The following table shows recent insider sales of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 21, 2026 | Javadi Alireza | officer: Chief Technical Officer | Sell | 386 | $0.78 | $301.08 | 9,689 |
| Jul 21, 2026 | Imran Talat | director, officer: Chief Executive Officer | Sell | 8,014 | $1.41 | $11.3K | 486,737 |
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 3,829,360 | $2.65 | $10.14M5.9% OS | 8,825,932-30% |
| Dec 8, 2023 | Quiroga Cortes Isidoro Alfonso | 10% Owner | Sell | 5,265,165 | $2.01 | $10.58M8.1% OS | 8,400-100% |
RANI Insiders
Imran Talat
director, officer: Chief Executive Officer
Bought $131.7KSold $11.3K
7 tradesLast: Jul 21, 2026
South Cone Investments Limited Partnership
10% Owner
Bought $12.78MSold $10.14M
40 tradesLast: Oct 17, 2024
Similar Stocks to RANI
VRTX
Vertex Pharmaceuticals Incorporated
$513.52-1.17%
$132.26B
REGN
Regeneron Pharmaceuticals, Inc.
$772.87-2.63%
$83.21B
MRNA
Moderna, Inc.
$142.93-2.49%
$57.13B
RVMD
Revolution Medicines, Inc.
$204.47-0.31%
$44.15B
INSM
Insmed Incorporated
$119.56-4.63%
$28.05B
INCY
Incyte Corporation
$121.65-0.43%
$24.62B
UTHR
United Therapeutics Corporation
$500.44-0.42%
$21.10B
NBIX
Neurocrine Biosciences, Inc.
$150.44-4.31%
$15.71B